JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $187,000 | +88.9% | 27,585 | +132.5% | 0.00% | – |
| Q4 2021 | $99,000 | +12.5% | 11,867 | 0.0% | 0.00% | – |
| Q3 2021 | $88,000 | +8.6% | 11,867 | 0.0% | 0.00% | – |
| Q2 2021 | $81,000 | -33.6% | 11,867 | 0.0% | 0.00% | – |
| Q1 2021 | $122,000 | +71.8% | 11,867 | +16.7% | 0.00% | – |
| Q4 2020 | $71,000 | – | 10,167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|